BTS guidelines for the management of malignant pleural effusions. - Wikidata - awgldk - TriplyDB

BTS guidelines for the management of malignant pleural effusions.

BTS guidelines for the management of malignant pleural effusions.

http://www.wikidata.org/entity/Q35577474

about

Malignant mesothelioma Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer Patient evaluation for rapid pleurodesis of malignant pleural effusions Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural Effusion BTS statement on malignant mesothelioma in the UK, 2007.Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.Thoracostomy tubes: A comprehensive review of complications and related topics Malignant pleural effusion and algorithm management Interpretation of PET/CT findings in patients with advanced lung cancer who have undergone pleurodesis Long-term results of pleurodesis in malignant pleural effusions: Doxycycline vs Bleomycin Efficacy & safety of iodopovidone pleurodesis: a systematic review & meta-analysis Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial Mortality of Hospitalized Patients with Pleural Effusions.Management of traumatic hemothorax by closed thoracic drainage using a central venous catheter.The Use of Indwelling Tunneled Pleural Catheters for Recurrent Pleural Effusions in Patients With Hematologic Malignancies: A Multicenter Study Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion Clinical management of pain in advanced lung cancer.Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer.Role of therapeutic thoracentesis in tuberculous pleural effusion A Novel Technique to Treat Air Leak Following Lobectomy: Intrapleural Infusion of Plasma.Recent advances in the palliative management of respiratory symptoms in advanced-stage oncology patients.The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion A pilot study-is there a role for mitoxantrone pleurodesis in the management of pleural effusion due to lung cancer?Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose.Treatment of malignant pleural effusion: a cost-effectiveness analysis.Significance of Total Protein, Albumin, Globulin, Serum Effusion Albumin Gradient and LDH in the Differential Diagnosis of Pleural Effusion Secondary to Tuberculosis and Cancer.Diagnostic and therapeutic performance of video-assisted thoracoscopic surgery (VATS) in investigation and management of pleural exudates Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction Prolonged pleural catheters in the management of pleural effusions due to breast cancer.Effect of topical tetracycline on seroma formation in the Lichtenstein technique: a prospective randomized study Advances in the investigation and treatment of pleural effusions.Imaging of the pleura.Diffuse neoplasms of the pleural serosa.The treatment of pleural carcinosis with malignant pleural effusion.Interventional therapies for malignant pleural effusions: the present and the future.Malignant pleural effusions: appropriate treatment approaches.Pleural effusion: diagnosis, treatment, and management.

P2860

Q21202901-DE13BC24-B5B7-4BAA-819C-A524A8E133E0 Q24796122-87AEE7E7-8753-4FA1-B2F1-FFAE8BB31E6A Q24807013-B732B91B-0763-4ABE-B18E-745C6E928E43 Q28822235-05CC0376-2F08-40C2-B16C-3B9318BA7FEF Q28830501-8F9AACC7-E50B-40FB-B7B6-8ADC5090E1B6 Q30478994-2B08CF80-29EC-42C7-9AB5-759C6015B1D2 Q33737084-826F7B42-F61E-4B45-B6A0-FF8ACDB0536B Q33888121-6B956B40-4553-4790-A984-FC9FEDD9C42B Q34038433-FB08CDCF-637C-461B-BAB1-E8E9AEB54C93 Q34089063-4E58A54E-E766-4B88-AA47-E2E6C8BF85C0 Q34170196-B74D8DFC-66FA-4D30-B764-802BD76C6D4E Q34273036-ABD0AB63-8709-4B09-A9F2-30726C9625AC Q34402445-173EBC0D-0DB0-4251-8E51-0127BFD713E4 Q34505962-36340B11-E498-4678-BB38-E152B330FBEC Q34814259-8BC2D58C-FA79-42A3-BD05-96AA3F40C8C4 Q35595856-BF1B10C7-FB32-439A-8F84-CD3F8DFE9C47 Q35653346-3086B0C1-646C-4BB4-8700-01A491D54889 Q36015469-488B2321-C21D-4E73-A25E-776DC2FE15F2 Q36224299-8D77B44F-A34C-4E86-A9B3-66603EB06449 Q36327481-6A95B149-E552-4EE9-93B7-1FA9D4BD1747 Q36412060-81C0FABF-5EA1-47BB-9A1B-B5E97C7556BE Q36422679-CA989170-873A-4FBB-89FB-71A40D17DC37 Q36808230-6E3ED584-EF66-4350-AB23-05670D9F7977 Q36821774-4C4A01AC-8ADD-4808-A3FD-525AB90626F7 Q36907325-755C0744-1099-4185-AB7E-75EB8183F729 Q36924922-5732905E-DDAC-405D-95D1-DA2249F8AF5F Q37098477-E26CC934-0C08-4BF3-B1ED-6B0B4EF97DD4 Q37199528-3C546506-AFAC-4C1F-9E71-F490D3BE17E8 Q37266612-970B5039-B752-4A61-9087-6E8364CB982E Q37308918-43C74A34-C3CA-443A-81C7-2D54435F2FEF Q37542587-3CB646AF-5271-47A8-B9B7-9A06610EFC21 Q37620520-60F07FEA-5A87-4A73-A799-3421C634C263 Q37670898-ABF6BE6D-8A9E-42BD-9C2D-4416216CABF3 Q37730006-77F6D487-48C3-45F3-B1ED-284E48C38755 Q37812072-B6912916-B819-4A9A-B311-76A8D42A1A34 Q38044217-D96041FE-D3FF-4B76-A667-59714C84AD45 Q38110545-DB5C6195-0B56-46A1-93B4-B9E6CFA22B28 Q38221769-B5E3ED87-F7D5-4F88-A430-B41B64D838B7 Q38327770-B0DA1710-2FDF-413A-A02E-830F009136BF Q38449310-A58A08BE-F18D-40CD-91FE-E3ABE8A240D4

P2860

BTS guidelines for the management of malignant pleural effusions.

http://www.wikidata.org/entity/Q35577474

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

BTS guidelines for the management of malignant pleural effusions.

@ast

BTS guidelines for the management of malignant pleural effusions.

@en

type

label

BTS guidelines for the management of malignant pleural effusions.

@ast

BTS guidelines for the management of malignant pleural effusions.

@en

prefLabel

BTS guidelines for the management of malignant pleural effusions.

@ast

BTS guidelines for the management of malignant pleural effusions.

@en

P1433

Q35577474-6F8C5B37-01A7-4419-99C1-D0EDDF021632

P1476

Q35577474-369F9146-CB5E-458F-A3C0-C1D2F332E0FB

P2093

Q35577474-1D492C70-0D6D-4E37-901C-54A5FA91C9CF

Q35577474-26C69BC7-84E7-407C-90E6-028772D744E6

Q35577474-67590E9E-1188-4792-A988-215B37979A4B

Q35577474-BAE94209-5E92-4214-A5B3-E80E6ADC781B

Q35577474-DE7F41E3-EF18-460A-B1B8-D5844A9E1E01

P2860

Q35577474-0075B736-6B65-440D-91E9-564B8AD0AE8F

Q35577474-1158120F-3AA5-488A-AC32-1B34DC484C0F

Q35577474-13D56D0A-909E-4F10-B4DC-CFAD0333401E

Q35577474-19EFC622-AF9D-4CD8-A9D2-87B0F15E9CD7

Q35577474-1E434DBA-2D29-4A15-9918-AEEC810AD386

Q35577474-23553B10-9D15-43F0-ABED-3965A7416EE3

Q35577474-2572D51F-5636-45CA-B0C4-E1C08FA32035

Q35577474-257F23D9-0531-4FCE-B452-2ECC4C68DFF7

Q35577474-27412DF8-EE40-400D-A9FE-F4205D7CB90F

Q35577474-2F8F15CE-773C-4344-ABD7-A832E344CBCF

P304

Q35577474-B7A725A0-F1E9-49BA-B379-0CA176BB4B63

P31

Q35577474-B3DB4805-A5E9-464C-9940-D43AC2E367C4

P356

Q35577474-244E27D7-FFE4-42FD-B41C-45709169BCC3

P407

Q35577474-2A6B861E-888A-437A-9E73-F31C9B88E147

P478

Q35577474-5E92A178-C1B1-434A-83EA-DB57B05970C5

P577

Q35577474-CB2F120D-8B08-4057-B6FF-5005922C8E64

P5875

Q35577474-DB3E02E9-A423-405E-9230-5AB308778D3D

P698

Q35577474-AA7EB6C8-E7A4-4468-A2C5-0CC0D9D2F5B4

P932

Q35577474-7BC06E41-82FE-4C68-95D2-6CAF4BB474C5

P356

THX.58.SUPPL_2.II29

P1433

P1476

BTS guidelines for the management of malignant pleural effusions.

@en

P2093

E Neville

http://www.w3.org/2001/XMLSchema#string

G Antunes

http://www.w3.org/2001/XMLSchema#string

J Duffy

http://www.w3.org/2001/XMLSchema#string

N Ali

http://www.w3.org/2001/XMLSchema#string

Pleural Diseases Group, Standards of Care Committee, British Thoracic Society

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of malignant pleural effusions and talc pleurodesis.

Thoracoscopy talc poudrage : a 15-year experience.

THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

How should cancer presenting as a malignant pleural effusion be managed?

Further experience of Corynebacterium parvum in malignant pleural effusion.

Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.

Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions

Diagnosis and treatment of malignant pleural effusion.

Bleomycin pharmacokinetics in man. II. Intracavitary administration.

A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions.

P304

ii29-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.58.SUPPL_2.II29

http://www.w3.org/2001/XMLSchema#string

P407

P478

58 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10777199

http://www.w3.org/2001/XMLSchema#string

P698

12728148

http://www.w3.org/2001/XMLSchema#string

P932

1766015

http://www.w3.org/2001/XMLSchema#string